ZELLUNA IMMUNOTHERAPY AS
816823862ActivePioneering TCR-NK cell therapies to eliminate solid cancers safely.
Overview
- 9
- Employees
- 53K NOK
- Revenue
- 2016
- Founded
Key Decision Makers
Namir Hassan
Chief Executive Officer
Geir Christian Melen
Chief Financial Officer
Luise Weigand
Chief Scientific Officer
Michael Nishimura
Scientific Advisory Board Member
+15 more contacts in Funnelfeedr
Description
Zelluna is a biotechnology company dedicated to eradicating solid cancers through innovative immune therapies. Its core mission involves unleashing the immune system's power using pioneering T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK. This novel platform is desi...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Aksjeselskap
- VAT Number
- Unknown
Decision Makers
19 contacts in FunnelfeedrNamir Hassan
Chief Executive Officer
Geir Christian Melen
Chief Financial Officer
Luise Weigand
Chief Scientific Officer
Michael Nishimura
Scientific Advisory Board Member
Emilie Gauthy
Chief Technology Officer
Anders Holm
Chief Operating Officer and Head of Business Development
May Sabry
Scientific Advisory Board Member
Omid Hamid
Scientific Advisory Board Member
Eva-Lotta Allan
Board Member
Julia Ino
Head of Project Management
Bent Jakobsen
Board Member
Charlotte Sofie Bergsagel Berg-Svendsen
Board Member
Ulrike Köhl
Scientific Advisory Board Member
Øivind Foss
Head of Clinical Operations
Dirk Jäger
Scientific Advisory Board Member
Wolf Hervé Fridman
Scientific Advisory Board Member
Hans Ivar Robinson
Board Member
Joachim Midttun
Finance Manager
Other Contacts
Anders Tuv
Advisor
Similar Companies
20 similar companies in Funnelfeedr
Ultimovacs AB
0 employeesPioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
CELLMOVER AS
6 employeesPre-clinical immunotherapy company optimizing immune cell targeting for cancer.
Symcel AB
34 employeesLeading provider of rapid microbial detection via biocalorimetry technology.
BIO INVENTION AS
Clinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
CuraCell TX AB
5 employeesEuropean biotech developing personalized T-cell therapies for solid cancer tumors.
Browse More
ZELLUNA IMMUNOTHERAPY AS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo